SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-20-000146
Filing Date
2020-08-31
Accepted
2020-08-31 09:04:16
Documents
16
Period of Report
2020-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-20200831.htm   iXBRL 8-K 41063
2 PRESS RELEASE a202008318-kex991.htm EX-99.1 17268
8 LOGO pdllogoa351.jpg GRAPHIC 123123
  Complete submission text file 0000882104-20-000146.txt   372311

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20200831.xsd EX-101.SCH 2405
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20200831_cal.xml EX-101.CAL 698
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20200831_def.xml EX-101.DEF 1631
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20200831_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20200831_pre.xml EX-101.PRE 12634
9 EXTRACTED XBRL INSTANCE DOCUMENT pdli-20200831_htm.xml XML 10461
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 201149959
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences